Skip to main content
Log in

Efficacy of albendazole and mebendazole againstHymenolepis microstoma andHymenolepis diminuta

  • Original Investigations
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

An investigation of the chemotherapeutic effects of 2 anthelmintics, albendazole (ABZ, methyl 5-[propylthio]benzimidazole-2-carbamate) and mebendazole (MBZ, methyl 5-[benzoyl]benzimidazole-2-carbamate), onHymenolepis microstoma andHymenolepis diminuta in experimentally infected mice and rats is reported. Single (50 mg/kg) or multiple daily oral doses (50 mg kg−1 day−1 for 3 consecutive days) of MBZ had no effect onH. microstoma; at necropsy, the drug treated mice harbored appreciable numbers of the parasite in the bile duct and biliary passages. ABZ was also inactive when given as a single oral 50 mg/kg dose on day 27 PI. Better results were obtained when ABZ was administered at a dosage of 50 mg kg−1 day−1 for 3 consecutive days; the reduction in worm burden obtained with this treatment regimen was 50%. These results are in marked contrast to those obtained with the same anthelmintics against enteralH. diminuta in rats which succumbed at lower dosages. A review was made of the published reports on the pharmacokinetic behavior of these benzimidazole carbamate anthelmintics and a hypothesis for the inactivity of MBZ againstH. microstoma is proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Allan RJ, Watson TR (1982) Identification of biliary metabolites of mebendazole. Eur J Durg Metab Pharmacokinet 6:131–136

    Google Scholar 

  • Allan RJ, Watson TR (1983) The metabolic and pharmacokinetic disposition of mebendazole in the rat. Eur J Drug Metab Pharmacokinet 8:373–381

    Google Scholar 

  • Barrett J (1989) Detoxification reactions in panasitic helminths. In: Bennet E-M, Behm C, Bryant C (eds) Comparative biochemistry of parasitic helminths. Chapman and Hall, New York, pp 109–114

    Google Scholar 

  • Brody G, Elward TE (1971) Comparative activity of 29 known anthelmintics under standardized drug-diet and gavage medication regimens against four helminth species in mice. J Parasitol 57:1068–1077

    Google Scholar 

  • Delatour P, Parish RC (1986) Benzimidazole anthelmintics and related compounds: toxicity and evaluation of residues. In: Rico AG (ed) Drug residues in animals. Academic, New York, pp 175–204

    Google Scholar 

  • Delatour P, Parish RC, Gyurik RJ (1981) Albendazole: a comparison of relay embryotoxicity with embryotoxicity of individual metabolites. Ann Rech Vet 12:159–167

    Google Scholar 

  • Delatour P, Garnier F, Benoit E, Longin C (1984) A correlation of toxicity of albendazole and of oxfendazole with their free metabolites and bound residues. J Vet Pharmacol Ther 7:139–145

    Google Scholar 

  • Delatour P, Benoit E, Caude M, Tambute A (1990) Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats. Chirality 2:156–160

    Google Scholar 

  • Dvorak JA, Jones AW, Kuhlman HH (1961) Studies on the biology ofHymenolepis microstoma (Dujardin, 1845). J Parasitol 47:833–838

    Google Scholar 

  • Evans WS, Novak M (1976) The effect of mebendazole on the development ofHymenolepis diminuta inTribolium confusum. Can J Zool 56:1079–1083

    Google Scholar 

  • Evans WS, Gray M, Novak M (1979) Effect of mebendazole on the larval development of three hymenolepidid cestodes. J Parasitol 65:31–34

    Google Scholar 

  • Evans WS, Hardy M, Novak M (1980) A comparison of the effect of albendazole, cambendazole, and thiabendazole on the larval development of three hymenolepidid cestodes. J Parasitol 66:935–940

    Google Scholar 

  • Gottschall DW, Theodorides VJ, Wang R (1990) The metabolism of benzimidazole anthelmintics. Parasitol Today 6:115–124

    Google Scholar 

  • Greenblatt DJ, Koch-Weser J (1975a) Clinical pharmacokinetics (first of two parts). N Engl J Med 293:702–705

    Google Scholar 

  • Greenblatt DJ, Koch-Weser J (1975b) Clinical pharmacokinetics (second of two parts). N Engl J Med 293:964–970

    Google Scholar 

  • Gyurik RJ, Chow AW, Zaber B, Brunner EL, Miller JA, Villani AJ, Petka LA, Parish RC (1981) Metabolism of albendazole in cattle, sheep, rats, and mice. Drug Metab Dispos 9:503–508

    Google Scholar 

  • Hennessy DR (1985) Manipulation of anthelmintic pharmacokinetics. In: Anderson N, Waller PJ (eds) Resitance in nematodes to anthelmintic drugs. CSIRO Animal Health/Australian Wool Corporation, Sydney, pp 79–85

    Google Scholar 

  • Hennessy DR, Steel JW, Lacey E, Eagleson GK, Prichard RK (1989) The disposition of albendazole in sheep. J Vet Pharmacol Ther 12:421–429

    Google Scholar 

  • Kirk RE (1968) Experimental design: procedures for the behavioral sciences. Brooks/Cole Publishing Co., Inc., Belmont, California, pp 493–497

    Google Scholar 

  • Kunkle DW, Theodorides VJ (1971) Activity of parbendazole against cestodes in mice. J Parasitol 57:319

    Google Scholar 

  • Kwan LC, Gyurik RJ, Freeman JF, Chimes N, Ritch GM, Theodorides VJ (1988) Influence of dosing regimens on the anthelmintic activity of albendazole in sheep. J Controlled Release 8:31–38

    Google Scholar 

  • Marriner SE, Morris DL, Dickson B, Bogan JA (1986) Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 30:705–708

    Google Scholar 

  • McCracken RO, Lipkowitz KB (1990) Experimental and theoretical studies of albendazole, oxibendazole, and tioxidazole. J Parasitol 76:180–185

    Google Scholar 

  • McCracken RO, Nierste DM, Moss J, Garcia A (1984) Oxfendazole: regimen dependent expression of drug efficacy againstTrichinella spiralis. Int J Parasitol 14:309–312

    Google Scholar 

  • Meuldermans WEG, Hurkmans RMA, Lauwers WFJ, Heykants JJP (1976) The in vitro metabolism of mebendazole by pig, rat and dog liver fractions. Eur J Drug Metab Pharmacokinet 1:35–40

    Google Scholar 

  • Novak M, Evans WS (1978) The effect of mebendazole on different developmental stages ofHymenolepis diminuta cysticercoids. Can J Zool 56:604–607

    Google Scholar 

  • Novak M, Hardy M, Evans WS (1982) A comparison of the effects of ten, 5-substituted benzimidazolyl carbamates on larval development of three hymenolepidid tapeworms. J Parasitol 68:1165–1167

    Google Scholar 

  • Read CP, Rothman JH, Simmons JE (1963) Studies on membrane transport, with special reference to parasite-host integration. Ann New York Acad Sci 113:154–205

    Google Scholar 

  • Souhaili-El Amri H, Fargetton X, Benoit E, Totis M, Batt A-M (1988a) Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics. Toxicol Appl Pharmacol 92:141–149

    Google Scholar 

  • Souhaili-El Amri H, Mothe O, Totis M, Masson C, Batt A-M, Delatour P, Siest G (1988b) Albendazole sulfonation by rat liver cytochrome P-450c. J Pharmacol Exp Ther 246:758–764

    Google Scholar 

  • Townsend LB, Wise DS (1990) The synthesis and chemistry of certain anthelmintic benzimidazoles. Parasitol Today 6:107–112

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCracken, R.O., Lipkowitz, K.B. & Dronen, N.O. Efficacy of albendazole and mebendazole againstHymenolepis microstoma andHymenolepis diminuta . Parasitol Res 78, 108–111 (1992). https://doi.org/10.1007/BF00931650

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00931650

Keywords

Navigation